- Home
- NTHI vs LFMD Comparison
NTHI vs LFMD Comparison
Compare NTHI & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | LFMD |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.4M | 190.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTHI | LFMD |
|---|---|---|
| Price | $7.00 | $3.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 27.3K | ★ 1.3M |
| Earning Date | 05-19-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.11 |
| Revenue Next Year | N/A | $20.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.20 | $2.60 |
| 52 Week High | $15.50 | $15.34 |
Technical Indicators
Market Signals| Indicator | NTHI | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.52 | 49.60 |
| Support Level | $6.40 | $3.43 |
| Resistance Level | $7.70 | $4.04 |
| Average True Range (ATR) | 0.73 | 0.28 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 2.66 | 12.01 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.